It is not the case that Different domains face asymmetric costs: approving harmful drugs causes deaths; rejecting beneficial ones delays treatment. These aren't mathematically equivalent.
?Set your confidence on the premises below to see your aggregate.
No one has weighed in yet. Be the first to share reasons for or against this statement.